Association of Postoperative Morbidity with Survival and Recurrence Following Hepatectomy for Hepatocellular Carcinoma: A Large-Scale Multicenter Study

L. Liang,C. Li,H. Xing,Y.-M. Zhang,W.-G. Zhang,H. Wang,Y.-H. Zhou,T.-H. Chen,T. Yang

DOI: https://doi.org/10.1016/j.hpb.2020.11.072

IF: 3.842

2021-01-01

HPB

Abstract:Background and aims: Postoperative morbidity following hepatectomy for hepatocellular carcinoma (HCC) is common and its impact on oncological outcome remains unclear. To investigate if postoperative morbidity impacts long-term survival and recurrence after HCC resection. Methods: A multicenter database of curative-intent hepatectomy for HCC collected data from 10 Chinese hospitals. After excluding patients with postoperative early deaths (≤ 90 days), early (≤ 2 years) and late (> 2 years) recurrence rates, overall survival (OS), and time-to-recurrence (TTR) were compared between patients with and without postoperative morbidity. Results: Among 2,161 patients eligible for the study, 758 (35.1%), 29 (1.3%) and 67 (3.1%) had postoperative 30-day morbidity, 30-day mortality and 90-day mortality, respectively. Multivariable analysis showed that diabetes mellitus, obesity, Child-Pugh grade B, cirrhosis, and intraoperative blood transfusion were independent risks of postoperative morbidity. The rates of early and late recurrence among patients with postoperative morbidity were greater than those without (50.7% vs. 38.8%, P< 0.001; and 41.7% vs. 34.1%, P=0.017). Postoperative morbidity was associated with a significant reduction in median OS(48.1 vs 91.6 months; P< 0.001) and median TTR (19.8 vs 46.1 months; P< 0.001). After adjustment of confounding factors, multivariable Cox-regression analyses showed that postoperative morbidity was associated with a 27.8% and 18.7% greater likelihood of mortality (HR1.278; 95% confidence interval: 1.126-1.451) and recurrence (1.187; 1.058-1.331). Conclusions: This large multicenter study provides strong evidence that postoperative morbidity adversely impacts long-term oncologic outcomes after hepatectomy for HCC. The prevention and management of postoperative adverse events may be oncologically important.